Stephens Has Trimmed Its Merck & Co (MRK) Position; SPANISH BROADCASTING SYSTEM CLASS A (SBSAA) Shorts Up By 1300%

February 18, 2018 - By Adrian Mccoy

SPANISH BROADCASTING SYSTEM CLASS A (OTCMKTS:SBSAA) had an increase of 1300% in short interest. SBSAA’s SI was 21,000 shares in February as released by FINRA. Its up 1300% from 1,500 shares previously. With 69,700 avg volume, 0 days are for SPANISH BROADCASTING SYSTEM CLASS A (OTCMKTS:SBSAA)’s short sellers to cover SBSAA’s short positions. The stock increased 9.09% or $0.03 during the last trading session, reaching $0.36. About 20,963 shares traded. Spanish Broadcasting System, Inc. (OTCMKTS:SBSAA) has 0.00% since February 18, 2017 and is . It has underperformed by 16.70% the S&P500.

Stephens Inc decreased Merck & Co Inc (MRK) stake by 2.92% reported in 2017Q3 SEC filing. Stephens Inc sold 10,778 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Stephens Inc holds 357,766 shares with $22.91M value, down from 368,544 last quarter. Merck & Co Inc now has $153.36 billion valuation. The stock increased 0.54% or $0.3 during the last trading session, reaching $56.29. About 11.73 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since February 18, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

Spanish Broadcasting System, Inc. operates as a Spanish-language media and entertainment firm in the United States. The company has market cap of $2.62 million. It operates in two divisions, Radio and Television. It currently has negative earnings. The firm produces and distributes Spanish-language content, including radio programs, television shows, and music and live entertainment.

Stephens Inc increased Dollar Gen Corp New (NYSE:DG) stake by 9,322 shares to 28,057 valued at $2.27M in 2017Q3. It also upped Zimmer Biomet Hldgs Inc (ZMH) stake by 12,850 shares and now owns 38,991 shares. Apple Inc (NASDAQ:AAPL) was raised too.

Investors sentiment decreased to 1.06 in Q3 2017. Its down 0.01, from 1.07 in 2017Q2. It worsened, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Blair William And Il reported 429,615 shares or 0.21% of all its holdings. 22,272 were reported by Weaver C Barksdale Inc. Carlson Cap Management reported 3,922 shares stake. Beacon Group stated it has 0.06% in Merck & Co., Inc. (NYSE:MRK). Hutchin Hill Capital Limited Partnership stated it has 14,900 shares. 38.87M were accumulated by Bancorporation Of Ny Mellon Corp. Westwood Gp holds 0.02% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 35,885 shares. Aperio Gp Limited Liability, a California-based fund reported 1.63M shares. Parsons Capital Management Ri owns 99,874 shares. 138,364 are owned by Evercore Wealth Management Llc. Essex Finance Ser stated it has 43,521 shares or 0.68% of all its holdings. Piedmont Investment Advsr reported 682,675 shares stake. Assets Investment Mgmt Ltd Limited Liability Company invested in 0.82% or 64,100 shares. South State holds 0.36% or 49,645 shares in its portfolio. Yorktown Mngmt And Rech Incorporated has 4,500 shares for 0.08% of their portfolio.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 17 have Buy rating, 0 Sell and 7 Hold. Therefore 71% are positive. Merck & Co. Inc. had 79 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Wednesday, August 30 by Credit Suisse. The firm has “Sell” rating given on Friday, August 18 by Jefferies. The stock has “Hold” rating by Societe Generale on Wednesday, September 30. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Hold” rating by Jefferies on Friday, April 15. The stock of Merck & Co., Inc. (NYSE:MRK) has “Neutral” rating given on Wednesday, January 27 by Bank of America. The firm has “Hold” rating given on Friday, November 3 by Cowen & Co. The firm earned “Buy” rating on Friday, July 28 by SunTrust. Argus Research maintained Merck & Co., Inc. (NYSE:MRK) rating on Tuesday, November 17. Argus Research has “Buy” rating and $65 target. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, February 7. The company was maintained on Monday, October 30 by UBS.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>